Renault Samsung Motors Corp. may suspend the operation of its sole plant in South Korea for three to four days next month due to lower demand triggered by the COVID-19 pandemic.
The suspension would be done after the Chuseok holiday, which starts on Sept. 30 and lasts through Oct. 5.
The company intends to control inventories amid weak sales.
Renault Samsung and its labor union are in wage and collective agreement talks for the year 2020.
Renault Samsung's sales from January to August plummeted 27 percent to 84,158 vehicles from 114,705 units n the same period last year.
The company's car lineup includes the XM3 SUV, QM6 SUV, all-electric SM3 Z.E. sedan, and SM6 sedan.
Groupe Renault owns an 81 percent share in Renault Samsung.


Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 



